Israel Englander Seelos Therapeutics, Inc. Transaction History

Millennium Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.66 - $1.22 $104,363 - $192,914	-158,127 Reduced 25.31%	466,735 $560,000
Q1 2023 May 15, 2023	SELL	$0.59 - $1.04 $72,642 - $128,047	-123,123 Reduced 16.46%	624,862 $432,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $259.46 $112,914 - $44.4 Million	-171,083 Reduced 18.61%	747,985 $508,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $434,148 - $186 Million	-667,921 Reduced 42.09%	919,068 $947,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $0.93 $699,201 - $1.28 Million	1,370,984 Added 634.7%	1,586,989 $1.08 Million
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $455,523 - $927,315	-542,290 Reduced 71.51%	216,005 $181,000
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $941,260 - $1.41 Million	-591,988 Reduced 43.84%	758,295 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $892,642 - $1.53 Million	-528,191 Reduced 28.12%	1,350,283 $3.25 Million
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $3.26 Million - $7.8 Million	1,233,931 Added 191.44%	1,878,474 $4.96 Million
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $870,133 - $3.22 Million	644,543 New	644,543 $3.22 Million
Q2 2019 Aug 14, 2019	SELL	$2.11 - $3.3 $133,560 - $208,886	-63,299 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.45 - $8.1 $91,783 - $512,721	63,299 New	63,299 $213,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.